Oruka Therapeutics, Inc. · NASDAQ:ORKA
Klein Lawrence Otto sold 75,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Klein Lawrence Otto (Director, Chief Executive Officer) sold 75,000 Oruka Therapeutics, Inc. shares at an average US$91.84 for US$6.89M under a trading plan, leaving 925,580 shares. Filed Sep 1, 2026 (Form 4).
- Sold
- 75,000 shares
- Price
- US$91.84 average (US$90.79 to US$92.44)
- Value
- US$6.89M
- Holding after
- 925,580 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 75,000 | US$7.80 | 1,000,580 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 6,604 | US$90.79 | 993,976 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 63,596 | US$91.90 | 930,380 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 4,800 | US$92.44 | 925,580 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Klein Lawrence Otto
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Klein Lawrence Otto · Sep 15, 2026
- Form 4 · Klein Lawrence Otto · Jun 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026